Similar articles

• Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.

  Charreau B, Cassard A, Tesson L, Le Mauff B, Blanchard D, Lublin D, Soulillou JP, Anegon I. Charreau B, et al. Transplant Proc. 1995 Feb;27(1):336-7. Transplant Proc. 1995. PMID: 7533404 No abstract available.
• Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysis.

  Hayashi S, Isobe K, Emi N, Okada H, Yasutomi M, Negita M, Koike C, Uchida K, Yokoyama I, Takagi H. Hayashi S, et al. Transplant Proc. 1995 Feb;27(1):330. Transplant Proc. 1995. PMID: 7533402 No abstract available.
• Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.

  Brooimans RA, van Wieringen PA, van Es LA, Daha MR. Brooimans RA, et al. Eur J Immunol. 1992 Dec;22(12):3135-40. doi: 10.1002/eji.1830221216. Eur J Immunol. 1992. PMID: 1280224
• The possible role of membrane complement regulators in vasculitis.

  Daha MR. Daha MR. Behring Inst Mitt. 1993 Aug;(92):184-90. Behring Inst Mitt. 1993. PMID: 7504449 Review.
• Structure and function of decay accelerating factor CD55.

  Nicholson-Weller A, Wang CE. Nicholson-Weller A, et al. J Lab Clin Med. 1994 Apr;123(4):485-91. J Lab Clin Med. 1994. PMID: 7511675 Review.